Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

November 01, 1999; 53 (8) Brief Communications

Bilateral substantia nigra changes on MRI in a patient with encephalitis lethargica

Loh Ngai Kun, Sitoh Yih Yian, Lee Sze Haur, Helen Tjia
First published November 1, 1999, DOI: https://doi.org/10.1212/WNL.53.8.1860
Loh Ngai Kun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sitoh Yih Yian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee Sze Haur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Tjia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Bilateral substantia nigra changes on MRI in a patient with encephalitis lethargica
Loh Ngai Kun, Sitoh Yih Yian, Lee Sze Haur, Helen Tjia
Neurology Nov 1999, 53 (8) 1860; DOI: 10.1212/WNL.53.8.1860

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
3

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Article abstract A 33-year-old woman admitted for meningoencephalitis had features of encephalitis lethargica develop on her third day of illness. She had ophthalmoplegia, akinetic mutism, and prominent extrapyramidal signs consisting of lip and hand tremors, cogwheel rigidity, and facial bradykinesia.

Encephalitis lethargica is a rare disorder, with only sporadic cases mentioned in the medical literature after 1921.1-5 The diagnosis is clinical but is complicated by the lack of distinguishing factors.6,7 Howard and Lees8 proposed seven major diagnostic criteria for encephalitis lethargica, defining it as an acute or subacute encephalitic illness with at least three of the following criteria: 1) signs of basal ganglia involvement; 2) oculogyric crises; 3) ophthalmoplegia; 4) obsessive-compulsive behavior; 5) akinetic mutism; 6) central respiratory irregularities; and 7) somnolence or sleep inversion or both. Our patient presented herein fulfilled these criteria as she had parkinsonian features, ophthalmoplegia, and akinetic mutism.

Case report.

A 33-year-old woman with an upper respiratory tract infection was admitted for fever, headache, vertigo, and vomiting. Three days later, she had slowing of mentation and neck stiffness, with photophobia and blurred vision develop. At the same time, she had extrapyramidal features of slurred speech, facial bradykinesia, and cogwheel rigidity. CSF examination revealed a pleocytosis: cells 1350/mm3 (polymorphs 80%, lymphocytes 20%, erythrocytes occasional); globulins positive; total proteins, 1.95 g/L (0.1–0.4); chloride, 121 mmol/L (120–130); glucose, 2.2 mmol/L (2.5–5.5); blood glucose, 8.6 mmol/L. CSF cultures for bacteria, mycobacteria, fungi, and viruses (herpes simplex, measles, mumps, Flavivirus) were negative.

She was treated for bacterial meningitis and responded within 1 week, with the repeat CSF showing a reduction of cells of 76 (lymphocytes 90%, polymorphs 10%, erythrocytes occasional) and proteins of 0.8 g/L.

However, she continued to be slow in mentation, and the facial bradykinesia and cogwheel rigidity worsened, until she was bedbound 15 days into her admission. Coarse tremors of her tongue, lips, and upper limbs developed. Her speech became increasingly slurred until there was complete absence of voluntary tongue movements. There was a sixth-nerve palsy with failure of abduction of the left eye.

The patient was diagnosed as having encephalitis lethargica, a postmeningoencephalitic syndrome associated with extrapyramidal dysfunction, ophthalmoplegia, and akinetic mutism. She responded to treatment with madopar (Roche, Basel, Switzerland) 375 mg/day, selegiline 10 mg/day, and bromocriptine 30 mg/day and was able to walk 1 month into her admission. Her mental state and speech returned to normal, and her ophthalmoplegia resolved 3 months later. At this time, the patient had her madopar reduced to 187.5 mg/day, and the selegiline and bromocriptine were gradually tapered off.

The MRI on the tenth day of her admission showed hyperintense lesions in the substantia nigra bilaterally on T2-weighted images (figure 1A). The T1-weighted scan was normal other than for mild leptomeningeal enhancement at the cerebellar folia (figure 1B), a finding supportive of the clinical picture of meningoencephalitis. The second scan 3 weeks later showed better definition of the same lesions: hyperintense on T2- (figure 2A) and hypointense with rim high signal on T1-weighted images (figure 2B). At 3 months, when the patient was almost fully recovered except for residual facial bradykinesia, a third follow-up scan with additional isotropic diffusion-weighted imaging was performed. It showed the same bilateral symmetric substantial nigral abnormalities, which were isointense to cerebrospinal fluid on the T2- and diffusion-weighted scans (figure 3).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. (A) T2-weighted image on tenth day of admission shows bilateral hyperintense lesions in the substantia nigra (arrow). (B) Contrast-enhanced T1-weighted image on 10th day of admission shows leptomeningeal enhancement at the cerebellar folia.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. (A) Follow-up T2-weighted image 3 weeks later shows better definition of the bilateral substantia nigra abnormalities (arrow). (B) Follow-up unenhanced T1-weighted image 3 weeks later of bilateral substantia nigra abnormalities, which are hypointense with rim high signal (arrow).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Follow-up diffusion-weighted image at 3 months with the patient almost fully recovered shows complete suppression of signal and isointensity to cerebrospinal fluid in the substantia nigra abnormalities (white arrow).

The brainstem auditory-evoked response showed a reversal of the wave-V/wave-I amplitude on the left side, whereas the visual and somatosensory study results were normal. Electroencephalographic and polysomnographic study results were normal. Investigation results to exclude treatable causes of parkinsonism, including ceruloplasmin, copper, and heavy metals, were normal.

Discussion.

The MRI lesions illustrate several interesting points. First, they show that patients with encephalitis lethargica have a radiologic correlate. Although depigmentation of the substantia nigra has been described previously in pathologic specimens,9 this is the first report of a patient showing bilateral substantia nigra lesions on MRI. It will assist physicians in diagnosing this complicated syndrome. Second, the MRI lesions were well-localized to the substantia nigra and bilateral. They correlated well with the extrapyramidal signs in this patient. In a normal individual, the substantia nigra, a part of the basal ganglia that connects with the striatum (caudate nucleus and globus pallidus), consists of black pigmented cells and produces dopamine, a chemical transmitter. The basal ganglia, through the action of dopamine, is responsible for planning and controlling automatic movements of the body via the corticobasal ganglia-thalamic pathway. Dopamine depletion from bilateral substantia nigra disease, as in this patient, interrupts this pathway and produces bradykinesia and rigidity. However, it is unclear why the substantia nigra is selectively involved in meningoencephalitis. Unfortunately, we could not isolate the etiologic agent as both the bacterial and viral cultures from the cerebrospinal fluid were negative. Third, the MRI lesions show the rapid nature and subsequent progression of the disease. The first MRI 10 days into her admission revealed changes in the substantia nigra bilaterally, suggesting a fairly acute process. The second MRI 3 weeks later showed unusual hypointense lesions with rim high signal on T1-weighted images. The cause of the rim high signal is unclear but may represent paramagnetic ion trapping. These changes were still present 3 months later, suggesting that they were likely to represent areas of focal damage with subsequent cystic encephalomalacia. In conclusion, although depigmentation of the substantia nigra has been described previously in pathologic specimens of patients with encephalitis lethargica, this is the first case of a patient showing bilateral substantia nigra changes on MRI.

  • Received December 30, 1998.
  • Accepted July 29, 1999.

References

  1. ↵
    Ravenholt RT, Foege WH. Influenza, encephalitis lethargica, parkinsonism. Lancet 1982;2:860–864.
    OpenUrlPubMed
  2. Espir MLE, Spalding JMK. Three recent cases of encephalitis lethargica. Br Med J 1956;1:1141–1144.
    OpenUrlPubMed
  3. Duvoisin RC, Yahr MD. Encephalitis and parkinsonism. Arch Neurol 1965;12:227–239.
  4. von Economo C. Encephalitis lethargica: its sequelae and treatment. Trans Newman KD. London: Oxford University Press, 1931.
  5. ↵
    Al-Mateen M, Gibbs M, Dietrich R, Mitchell WG, Menkes JH. Encephalitis lethargica-like illness in a girl with mycoplasma infection. Neurology 1988;38:1155–1158.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Rail D, Scholtz C, Swash M. Post-encephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry 1981;44:670–676.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Williams A, Houff S, Lees AJ, Calne DB. Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism. J Neurol Neurosurg Psychiatry 1979;42:790–792.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Howard RS, Lees AJ. Encephalitis lethargica: a report of four recent cases. Brain 1987;110:19–35.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Bojinov S. Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci 1971;12:383–415.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Case report.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis
    S. Pradhan, N. Pandey, S. Shashank et al.
    Neurology, November 01, 1999
  • Resident and Fellow Section
    Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis
    H.M.H. Braakman, V.M.P. Moers-Hornikx, B.M.G. Arts et al.
    Neurology, September 06, 2010
  • Brief Communications
    An unusual case of Creutzfeldt-Jakob disease
    F.J.G. Vingerhoets, I. Hegyi, A. Aguzzi et al.
    Neurology, August 01, 1998
  • Historical Neurology
    The centennial lesson of encephalitis lethargica
    Bart Lutters, Paul Foley, Peter J. Koehler et al.
    Neurology, March 19, 2018
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise